QLTI Biotech Ideas Portfolio - Stockpickr! Your Source for Stock Ideas

QLTI Biotech Ideas

650 views

TheStreet.com Rating: B-

Rate Now:

average rating: 0.00 / 0 ratings

printer friendly

send to a friend

Created by RocketStocks

DESCRIPTION:

Date updated:02-20-2009

To say we are in a market of historical dislocations is to state the obvious these days. One interesting dislocation is between a company’s market capitalization (total shares outstanding multiplied by its current price per share) and the associated net cash on that company’s balance sheet.
Due to massive deleveraging across all asset classes, interesting short and long term opportunities are being created---particularly

QLTI
Qlt Inc.
$3.63
0.00%
$N/A

But QLT has $155.95 million in cash sitting on its balance sheet! With that market cap, that amount of cash and zero debt, QLT is trading with a negative enterprise value of $8.2 million. And companies with negative EVs are always worth looking at. QLT, a small biotech firm based in Vancouver, Canada, makes prostate cancer drug Eligard, macular degeneration drug Visudyne and acne treatment Aczon.

People owning QLTI also tend to own: BCRX PLB SAI CPE ESGR BABY BIIB

TheStreet.com Rating: C What is this?

GS
Goldman Sachs Grp
$176.51
-0.03%
$176.40

Even better, QLT hired Goldman Sachs as a financial adviser, and QLT management is looking to sell off this part of the business. Merrill Lynch says that Eligard is worth $150 million to $180 million, while RBC says $125 million to $145 million.

People owning GS also tend to own: AOB COGO CRYP GEL GLW GRMN MDRX

TheStreet.com Rating: C What is this?

DNA
N/a
$80.43
0.00
$80.43

No Analysis added

People owning DNA also tend to own: AAPL DSCM GOOG XOM DW ELX GLW

TheStreet.com Rating: B What is this?

PFE
Pfizer Inc
$17.56
+0.75%
$17.32

No Analysis added

People owning PFE also tend to own: BR MRK MSFT MWRK UL USG WU

TheStreet.com Rating: C+ What is this?

AMGN
Amgen Inc.
$54.10
-1.48%
$54.92

No Analysis added

People owning AMGN also tend to own: AAPL GE SGP CECE MRVL OMRI ANF

TheStreet.com Rating: B What is this?

BIIB
Biogen Idec Inc
$45.51
+0.22%
$45.43

No Analysis added

People owning BIIB also tend to own: APOL BRK-B DELL ELOS LXK SAFM SGTL

TheStreet.com Rating: B What is this?

MRK
Merck Co Inc
$33.61
+0.54%
$33.51

No Analysis added

People owning MRK also tend to own: ACAS CLP HPQ PHI SHFL VZ BR

TheStreet.com Rating: B- What is this?

CELG
Celgene Corporati
$53.65
-0.91%
$54.24

No Analysis added

People owning CELG also tend to own: GT IACI RAD STXN VAR ASH BNI

TheStreet.com Rating: B- What is this?

Comments not available

Top Do-It-Yourself Portfolios
» Joy
» tsamanuli Portfolio 1
» Albo's First Portfolio
» Fundsonly Portfolio 1
» rk00005
show all

Squeezing the Shorts: Large-Cap ...

By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...

11.11.09 | 15:19 PM

Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...

11.10.09 | 15:04 PM

This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...

11.09.09 | 11:01 AM

Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...

11.09.09 | 08:04 AM

General market Technical Analysi...

11.14.07 | 22:55 PM From author ZA

Cartoon Thread

11.15.07 | 20:31 PM From author Peter near Matanzas Inlet

Nymph's Trading Daily Trading Diary

04.13.09 | 01:10 AM From author Trading Nymph

The Presidential/Political Thread

01.02.08 | 08:05 AM From author Dave Cox

more forums